News 30 Abr 2024 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
News 10 Mayo 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
News 23 Abr 2024 BGG from China opens headquarters in Basel BGG is establishing new global headquarters in Basel, from which it plans to grow in Europe and the USA. The Beijing-based company is a supplier ...
Actualités 30 Abr 2024 Les Grands Titres de Suisse occidentale (Avril 2024) De percées biotechnologiques à la transformation des essais cliniques, en passant par des avancées dans le domaine des matériaux écologiques et d...
News 09 Abr 2024 Idiap’s 2024 nine-day AI Super Hackathon to transform ideas into prototypes From August 20th to 28th, 2024, the Idiap Research Institute in Martigny will become the epicenter of AI innovation.
News 19 Dic 2023 Top Stories from Western Switzerland (October-December 2023) From achieving top rankings in global innovation to making significant advancements in healthcare and technology, discover Western Switzerland's ...
最新 25 Dic 2023 瑞士初创公司 Zynnon在呼吸道感染的诊断方面实现突破 Zynnon在诊断病毒性呼吸道感染的技术上实现突破。在医院成功研究后,这家来自大苏黎世地区的公司已开始生产原型。随后还将进行进一步的临床试验。
Actualités 17 Abr 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
Actualités 09 Abr 2024 Le Super Hackathon IA 2024 de l’Idiap transforme les idées en prototypes Du 20 au 28 août 2024, l’Institut de recherche Idiap à Martigny deviendra l’épicentre de l’innovation en matière d’intelligence artificielle.
News 03 Nov 2023 EPFL and Novochizol to collaborate on designing more efficient immunotherapies A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...
News 04 Dic 2023 Siegfried, a Swiss leader taking innovations to industrial scale for the pharmaceutical industry From a small operation in Aargau to a global CDMO powerhouse, Siegfried's journey reflects strategic growth, innovation, and a deep commitment to...
Aktuell 10 Mayo 2024 BioVersys erweitert Serie-C-Runde auf 44,9 Millionen Franken BioVersys verstärkt die Zusammenarbeit mit GSK, um die Entwicklung von Alpibectir zur Behandlung von Tuberkulose zu beschleunigen. GSK beteiligt ...
Aktuell 22 Ago 2023 Cerefort beruft Christine Lang in den Wissenschaftlichen Beirat Christine Lang nimmt Einsitz im Wissenschaftlichen Beirat des Getränkeunternehmens Cerefort. Die deutsche Mikrobiologin ist im Vorstand der Belan...
News 29 Feb 2024 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...
Aktuell 30 Abr 2024 Johnson & Johnson eröffnet Innovation Hub in Allschwil Johnson & Johnson hat im Switzerland Innovation Park Basel Area den ersten J&J Innovation Hub auf dem europäischen Festland eröffnet. Es stellt e...
News 18 Oct 2023 Cimeio collaborating with the University of Pennsylvania The Basel-based start-up Cimeio has been offered an exceptional opportunity for a preclinical research collaboration with the University of Penns...
Actualités 18 Mar 2024 Neuria intègre l’accélérateur Vanguard pour promouvoir des modes de vie plus sains Neuria Digital Therapeutics est la première start-up de 2024 à bénéficier du programme Vanguard Accelerator.